The Spanish regulatory agency has approved the APRIL clinical trial, a Phase 1b/2a study to assess the safety and efficacy of ApTOLL in acute ischemic stroke patients.
We use our own and third-party cookies to improve our services and show commercials related to your own preferences through the analysis of your browsing habits. Clicking Accept entails your acceptance in using them.
You can change this configuration or obtain additional information on legal warning.ACCEPT